Overcoming Complexity in Cell Therapy Supply Chains
Author(s): Ashish Patil
Publication #: 2506030
Date of Publication: 23.06.2025
Country: USA
Pages: 1-11
Published In: Volume 11 Issue 3 June-2025
DOI: https://doi.org/10.5281/zenodo.15719033
Abstract
Cell therapy presents a groundbreaking advancement in personalized medicine, offering potential cures for conditions previously considered untreatable. However, the development, manufacturing, and delivery of these therapies involve highly complex, time-sensitive, and individualized processes that place unprecedented demands on supply chain infrastructure. Unlike traditional pharmaceutical supply chains, cell therapy supply chains must accommodate autologous products derived from individual patients, extreme cold chain logistics, rapid turnaround times, and stringent regulatory oversight. This paper explores the unique complexities of the cell therapy supply chain, identifies the key challenges faced by manufacturers and logistics providers, and proposes a combination of cited strategies and original recommendations. Key focus areas include traceability, orchestration, digital twins, cold chain integrity, regulatory harmonization, and AI-driven optimization. Quantitative insights and real-world case studies are incorporated, and the paper concludes with a roadmap for improving supply chain reliability, scalability, and patient outcomes.
Keywords:
Download/View Count: 8
Share this Article